Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer

Hypomethylation of the IGF2 DMR in Colorectal Tumors, Detected by Bisulfite Pyrosequencing, Is Associated With Poor Prognosis

(2010) Yoshifumi Baba et al.   GASTROENTEROLOGY

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues

(2009) R. Zhao et al.   CARCINOGENESIS

CTCF: Master Weaver of the Genome

(2009) Jennifer E. Phillips et al.   CELL

Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells

(2009) Thanh H. Vu et al.   HUMAN MOLECULAR GENETICS

Evidence for field cancerization of the prostate

(2009) Larisa Nonn et al.   PROSTATE

Aging and Cancer-Related Loss of Insulin-like Growth Factor 2 Imprinting in the Mouse and Human Prostate

(2008) V. X. Fu et al.   CANCER RESEARCH

Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer

(2008) Yoko Ito et al.   HUMAN MOLECULAR GENETICS

Distinct Methylation Changes at the IGF2-H19 Locus in Congenital Growth Disorders and Cancer

(2008) Adele Murrell et al.   PLoS One